Revenue

With its new biomimetic DexHand and massive funding, TARS isn't just building a robot hand. It's aiming to bridge the gap between AI and the physical world.

With profits set to triple, DL Holdings is moving beyond talk, launching a suite of AI platforms and a vision for tokenized living in Hong Kong.

Solidion Technology's stock is soaring on news of new battery patents for space and AI. But are its finances a red flag for savvy investors?

A landmark deal sees public funds back one of Europe's largest batteries, a project in Scotland set to redefine energy security and accelerate the green transition.

With its new SmartBioSurface slides, Italian firm Tethis aims to solve a major lab challenge. The key? A nanotech surface that could reshape disease research.

Japanese apparel innovator Classico is bringing Pikachu to patient care, launching its hit Pokémon scrubs across Asia to transform the medical uniform.

A new ranking names the 100 people controlling AI's answers. But beyond the list lies a deeper story about a fundamental shift in power and influence.

At a key industry summit, Camel Energy unveiled a dual battery strategy for Europe, pairing advanced lithium-ion with disruptive sodium-ion technology.

Agoda is selling serenity by promoting Asia's 'hidden' retreats. But as the wellness travel market booms, what is the true cost for these fragile destinations?

Agoda data reveals a surge in solo travel in Taiwan, redefining 'Love Day' and signaling a powerful economic shift towards individual-centric experiences.

Rokid's $4M Makuake success isn't just a record; it's a signal. With AI translation as the killer app, are smart glasses finally moving from niche to necessary?

A junior explorer just raised millions to follow up on a stunning 2013 gold find. Is it a long shot, or a savvy play on Saskatchewan's resource boom?

At Shanghai's CHINA CYCLE expo, CST Tires unveiled more than just lightweight tech; it showcased a strategic pivot that could redefine global manufacturing.

In a city chasing luxury, one iconic resort is doubling down on affordability and classic fun. We explore how Circus Circus is innovating by looking back.

The 10-year extension for the Las Vegas Grand Prix is more than a race deal; it's a high-stakes maneuver cementing F1's US strategy amid local growing pains.

A new, ultra-premium bourbon honors Secretariat's greatest win. But this is more than a drink; it's a case study in legacy, luxury, and market disruption.

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.

DBV Technologies heads to a key investor conference with its VIASKIN patch for peanut allergies. Can its science and strategy convince Wall Street?

Ottawa unveils a multi-billion dollar plan to transform Canada from an AI research hub into an economic leader, focusing on adoption, sovereignty, and ethics.

Ottawa's new "AI for All" plan promises to revolutionize healthcare, but can its 'ironclad protections' keep pace with the technology it's unleashing?